Related Experiment Video

Updated: Jul 12, 2026

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

The evolving biology and treatment of prostate cancer

Russel S Taichman1, Robert D Loberg, Rohit Mehra

  • 1University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, USA.

The Journal of Clinical Investigation
|September 6, 2007
PubMed

Insights

Androgen deprivation therapy is key for advanced prostate cancer treatment. Challenges persist in diagnosing relevant cancers and managing metastatic, androgen-independent disease in aging populations.

Area of Science:

  • Oncology
  • Urology
  • Cancer Biology

Background:

  • Androgen deprivation therapy (ADT) has been a cornerstone in treating advanced prostate cancer since its effectiveness was established.
  • Prostate cancer treatment exemplifies a systematic approach targeting cancer cells and their microenvironment.
  • Aging populations face increasing prostate cancer prevalence, highlighting diagnostic and management challenges.

Purpose of the Study:

  • To review the current landscape of prostate cancer treatment strategies.
  • To emphasize the importance of understanding the disease's biology for prevention and therapy.
  • To address the persistent challenges in managing clinically relevant prostate cancer, including metastatic and androgen-independent states.

Main Methods:

  • Review of established and emerging prostate cancer therapeutic principles.
  • Analysis of the biological underpinnings of prostate cancer progression.
  • Examination of diagnostic and management strategies for advanced disease states.

Main Results:

  • ADT remains a critical therapeutic modality for advanced prostate cancer.
  • Targeting both cancer cells and their microenvironment is a key treatment strategy.
  • Significant challenges exist in diagnosing relevant prostate cancer and managing metastatic disease.

Conclusions:

  • Understanding prostate cancer biology is crucial for developing effective prevention and treatment strategies.
  • Current therapeutic approaches effectively target cancer cells and their microenvironment.
  • Improved methods for diagnosing clinically relevant prostate cancer and managing metastatic, androgen-independent disease are needed.

More Related Videos

Enhancing Prostate Tumor Biobanking Reliability with Improved Sampling Technique and Histological Characterization07:34

Enhancing Prostate Tumor Biobanking Reliability with Improved Sampling Technique and Histological Characterization

Published on: November 17, 2023

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer13:19

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

Related Concept Videos

Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...